Skip to main content
. Author manuscript; available in PMC: 2013 Sep 23.
Published in final edited form as: Cancer. 2010 Nov 8;117(7):1334–1349. doi: 10.1002/cncr.25714

Table 2.

Risk Factors for VTE in Patients With Cancer

Category Risk Factor
Patient
characteristics
  • Advanced age

  • Gender

  • Ethnicity
    • ○ African American, higher
    • ○ Asian, lower
Cancer-related
factors
  • Cancer site
    • ○ Brain
    • ○ Pancreas
    • ○ Kidney
    • ○ Stomach
    • ○ Bladder
    • ○ Gynecologic
    • ○ Lung
    • ○ Blood
  • Advanced stage

  • Initial post-diagnosis

Biomarkers
  • Increased platelet count prior to chemotherapy

  • D-dimer

  • Tissue factor expression in tumor cells

Treatment-related
factors
  • Major surgery

  • Hospitalization

  • Cancer therapy

  • Chemotherapy or hormonal therapy

  • Antiangiogenic and immunomodulatory agents
    • ○ Bevacizumab
    • ○ Thalidomide and lenalidomide
  • Erythropoiesis-stimulating agents

Reprinted from Thrombosis Research, Vol 120 Supplement 2, Alok A. Khorana, Maithili V. Rao, Approaches to risk-stratifying cancer patients for venous thromboembolism, Pages No. S41-S50, Copyright 2007, with permission from Elsevier.14